secwatch.observer — SEC 8-K summary
======================================

Issuer:     ProMIS Neurosciences Inc. (PMN)
CIK:        0001374339
Form:       8-K
Filed at:   2024-10-10T23:59:59+00:00
Accession:  0001558370-24-013244
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Neil Warma appointed President and CEO of ProMIS Neurosciences, effective August 1, 2024
--------------------------------------------------------------------------------

- Base salary of $500,000 with annual discretionary bonus target of 50% of base salary.
- Granted option to purchase 1,144,122 common shares (Initial Award) and 490,338 shares (Performance Award) at $1.15 per share.
- Initial Award vests 25% on grant, remainder ratably over 36 months; Performance Award vests 25% when 10-day VWAP exceeds 3x exercise price, remainder over 36 months.
- Severance: 12 months' salary plus pro-rated bonus and time-based option acceleration on non-CIC termination; 18 months' salary plus benefits on change-in-control termination.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1374339/000155837024013244/0001558370-24-013244-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1374339/000155837024013244/pmn-20241008x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-013244

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer